
In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Virat Kohli Can Join Sachin Tendulkar Special Club WI vs IND Test Series After losing the final o
The price of the Indian rupee is determined by the market and there has been no decline in its va
Cyber Security Course: UGC Directives - Start Cyber Security Courses in Universities, Colleges
Cybercrime is spreading day by day in our society. Every day there are cases of cyber fraud by so
7 soldiers killed as army vehicle falls into river in Ladakh, Air Force taking injured to hospital
A major accident happened in Ladakh. The army vehicle slipped off the road and fell into the Shyo
Exclusive: Owaisi lashed out at BJP over Uniform Civil Code, said- I will protest
All India Majlis-e-Ittehadul Muslimeen (AIMIM) chief Asaduddin Owaisi arrived on a two-day Gujara
Greece Earthquake: 5.5 magnitude earthquake in Greece, tsunami feared, no casualties reported
Earthquake tremors were felt on the Greek island of Crete on Monday morning. After which people r
RBI: RBI's MPC meeting from today, this will be a big decision to deal with inflation
The meeting of the Monetary Policy Committee of the Reserve Bank of India will begin today. The c
CTET 2024: Another chance to register for CTET July, the deadline extended till this day; apply soon
CTET July 2024: The Central Board of Secondary Education has extended the last date for submissio
History was made last night when 14-year-old Indian American student Harini Logan won the title i
Shraddha Kapoor: Fans upset with Shraddha Kapoor's cryptic post, asked if the account was hacked?
Bollywood actress Shraddha Kapoor is very active on social media. She keeps sharing things relate